Shandong Weigao reports significant treasury share movements in September

For the month ended September 30, 2025, Shandong Weigao Group Medical Polymer Company Limited reported a decrease of 10,873,600 in its issued H shares (excluding treasury shares), bringing the total to 4,500,490,324. Concurrently, the number of H treasury shares increased by 10,873,600, reaching a total of 21,842,000. The overall total number of issued H shares remained unchanged at 4,522,332,324.

The company engaged in multiple H share repurchases throughout September 2025. These transactions ranged in price from HK$5.6388 to HK$5.891 per share. Notable repurchases included 1,954,800 shares on September 17 and 1,140,000 shares on September 9.

The company's total authorized/registered share capital at the end of the month was RMB457,063,232.4, comprising 4,522,332,324 H shares at RMB0.1 each and 48,300,000 non-listed ordinary shares at RMB0.1 each. The issued non-listed ordinary shares remained constant at 48,300,000.